Microbiology and Auditing. Don Singer
|
|
- Randall Lyons
- 7 years ago
- Views:
Transcription
1 Microbiology and Auditing Don Singer ASQ Northeast Pharmaceutical GMP/Quality Conference 2011
2 Through the eyes of a Microbiologist
3 Microbiology Audit = Inspection / Investigation
4 Systematic Auditing Planning Right People Tools Appropriate Objectives
5 Auditing approach Corporate design or policy Team Independent
6 Purpose Quality Systems Build robustness into your quality systems cgmps
7 Types of audits with Evaluation of Microbiological control Contract manufacture Contract microbiology laboratory Excipient manufacturer Active ingredient manufacturer Combination of any of the above Internal manufacture or laboratory
8 Quality Systems Inspection Quality system Production system Laboratory controls system Materials system Packaging and labeling system Facilities and equipment system
9 Microbiological Quality Risk Dosage form Management Laboratory tests Materials management
10 Risk by route of administration High Parenteral Ophthalmic Otic Wound topicals Nebulizer solution Intranasal solution Inhaled - DPI Inhaled - MDI Low Topical cream Topical ointment Oral solutions, suspensions Liquid-filled capsules Tablet, Capsule
11 Lab tests risk from impact of results High Sterility Test Bacterial endotoxin test Antimicrobial Preservatives Effectiveness Test Biological assays Microbial enumeration and Specified microorganisms tests Microbial identification Media growth promotion Low
12 Materials risk of contamination Manufacturing process Unprocessed High Classification Animal or plant origin (e.g. lactose) Highly processed Mineral origin (e.g. Talc) Some bioburden reduction processing Semi-synthetic origin (e.g. captisol, HPM) Mineral origin (e.g. dyes, aromatics) Low Synthetic origin (e.g. povidone)
13 Audit Expertise What is a QC Microbiologist? Knowledge Base : Science Origin and Growth Control
14 Microbiological Science
15 Origin and Growth Water (H 2 O) Nutrition (CHO, CHON, CHOOH, minerals, etc.) Presence or absence of components of air
16 Other Growth Factors ph temperature osmotic conditions light
17 Microbial Origin and Survival moderate to extreme environments solid to liquid dense to dilute atmosphere, humans and other living organisms (animals - vegetation), water, soil
18 Role of a QC Microbiologist Design for microbiological control Monitor to continuously evaluate
19 Control How to manipulate the environment Understand microbial growth limitations Determine how to reduce or eliminate microbial growth Understand dynamics of environment and microbiological growth / survival
20 Understand Thoroughly? Do you have the appropriate background and experience for microbiological investigation? If you do not, then partner with a Microbiologist
21 Tools to Assist cgmps, guidance docs, pharmacopeias Quality tools such as
22 Useful Quality Tools Assessment checklist or survey (developed by your Microbiologist colleague)
23
24 How does Risk fit Inspection decisions? High risk on-site inspection mandatory Moderate risk questionnaire assessment or on-site inspection Low risk questionnaire
25 Process flow chart Release of raw materials Fermentation Centrifugation Chromatography Bulk substance Filtration Final packaged product
26 Process analysis Excipients and Water Micronization Separation Drying Water Hydration Sterile filtration Filling
27 Details of Process with Controls HACCP plan Perform a virtual HACCP analysis using tour, procedures and assessment survey Amount of detail depends on level of risk
28 Audit Findings Template Same document format as Lead auditor Or Modified document for notes during audit For efficiency and clarity. Agreed on format with Lead auditor
29 Objectives I perform an audit with these intended goals: 1. Determine quality systems in place for microbiological control 2. Determine level of knowledge and capabilities of audited site 3. Determine if continuous improvement is part of culture
30 Objectives (cont.) 4. Determine if culture matches ours 5. Share knowledge and perspective with client where adds value 6. Develop a relationship based on respect, shared learning, communications
31 Right People Participants To ensure that adequate and timely information is generated during an audit Questions should be directed to the Microbiologist who has accountability and responsibility, and possibly to their staff Additionally, communicate with operators, or validation scientists, if appropriate (e.g. for sterile operations)
32 Success or Failure The results from an audit depend on the accuracy of information A non-microbiologist should have effective access to someone who is educated in pharmaceutical microbiology
33 Virtual Audit with a Microbiology Auditor
34 Criteria to Consider for Manufacturing Audits Excipient control C of A, specs, QC testing, material storage, weighing Process flow containment, gowning Process equipment validation, cleaning, sterilization, microbial monitoring Process areas cleaning, sanitization, access control, gowning, gloves, microbial monitoring, classification qualification Source of water, water system control and monitoring
35 Criteria to Consider for Manufacturing Audits Formulation excipient and component handling, bulk material handling, in-process sampling, hold time qualifications Dosage dependent manufacture controls (e.g. mixing, drying, milling, compaction) Finish/fill operations sampling, cleaning, operator technique/intervention, controls (e.g. filtration, sterilization, closure control), process qualification Finished product QC testing, stability testing
36 Criteria to Consider for Laboratory Audits Organization and reporting structure Laboratory layout Sample tracking, storage Media control, made or purchased Supplies, reagents control Instrument control calib., PM Lab and instrument cleaning, disinfection
37 Criteria to Consider for Laboratory Audits Lab monitoring SOPs and their control Microbial identification process Exceeded limit or atypical result procedure Quality improvement program, measures Proficiency testing Test methodology Method suitability procedures
38 Criteria to Consider for API or Excipient Manufacture Audit Process flow and contributing factors (e.g. intended use of compound, parenteral vs. non-sterile) Monitoring of process Origin and control of raw ingredients Water system control and monitoring Microbial monitoring of product
C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to
C 5 chemical development contract research custom synthesis cgmp API manufacturing commercial production Welcome to ChemCon Company profile Company profile ChemCon offers outstanding chemical services
More informationWorld Health Organization Prequalification of Medicines
Dr André van Zyl World Health Organization Prequalification of Medicines Manufacturers meeting April 2011 Head of Inspections vanzyla@who.int 1 WHO GMP In this presentation: Background and Introduction
More informationJournal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(2):892-898 World Health Organization s Guidelines for
More informationUnderstanding USP 797
DDK Scientific, Corp. Raul Duarte June 2008 Copyright DDK Scientific, Corp. 2008, 2009 DDK Scientific, Corp. Proprietary The purpose of USP 797 is to prevent harm and fatality to patients that could result
More informationTitle:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions
WELCOME Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions Contents: Introduction GMP Audit GMP Audit plan GMP Auditing
More informationDISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION
1 US FDA Form 483: A Case Study DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION DEVELOPED BY FRAN RABE 2 Introduction This case study is intended to extract portions of information
More informationHOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) GUIDANCE ON MODULE 3 OF THE HOMEOPATHIC MEDICINAL PRODUCTS DOSSIER
HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) GUIDANCE ON MODULE 3 OF THE HOMEOPATHIC MEDICINAL PRODUCTS DOSSIER DISCUSSION IN THE HMPWG 2003-2005 RELEASE FOR CONSULTATION December 2005 DEADLINE
More informationLibrary Guide: Pharmaceutical GMPs
Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA
More informationFDA and the Compounding Pharmacy
FDA and the Compounding Pharmacy Scott Sutton, Ph.D. scott.sutton@microbiol.org 41 Overview of Presentation The Recent Events GCP and GMP Basics the 483 Review H.R. 3204 Outsourcing Facility Preparation
More informationThe Microbial Bioburden of USP 797 Compliance. Simplifying Environmental Quality and Control Practices for Pharmaceutical Compounding
The Microbial Bioburden of USP 797 Compliance Simplifying Environmental Quality and Control Practices for Pharmaceutical Compounding PathCon Laboratories Fall 2009 Table of Contents Introduction a primer
More informationHazard Analysis and Critical Control Points (HACCP) 1 Overview
Manufacturing Technology Committee Risk Management Working Group Risk Management Training Guides Hazard Analysis and Critical Control Points (HACCP) 1 Overview Hazard Analysis and Critical Control Point
More informationGuidance for Industry
Guidance for Industry Changes to an Approved NDA or ANDA U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) April 2004 CMC Revision
More informationCONCEPTS OF FOOD SAFETY QUALITY MANAGEMENT SYSTEMS. Mrs. Malini Rajendran
CONCEPTS OF FOOD SAFETY AND QUALITY MANAGEMENT SYSTEMS Mrs. Malini Rajendran Brief background 1963 - The Codex Alimentarius Commission was created by FAO and WHO to develop food standards, guidelines and
More informationGuidance for Industry: Starting Material Supplier Management
Guidance for Industry: Starting Material Supplier Management Version 1.0 Drug Office Department of Health. Contents 1. Introduction... 3 2. Purpose of this document... 3 3. Scope... 3 4. Selecting and
More informationDRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.
Guidance for Industry Current Good Manufacturing Practice Interim Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act DRAFT GUIDANCE This guidance document is
More informationLeila Kakko Tampere University of Applied science TRADITIONAL FOOD IN COMBATING FOODBORNE PATHOGENS 2011
Leila Kakko Tampere University of Applied science TRADITIONAL FOOD IN COMBATING FOODBORNE PATHOGENS 2011 World Food Programme Food quality control is necessary to ensure that food aid supplies are safe,
More informationOn-Site GMP Training GMP COMPLIANCE TECHNICAL
PharmaNet On-Site GMP Training GMP COMPLIANCE TECHNICAL 284 E Lake Mead Pkwy Suite C-278 Henderson, NV 89015 Phone: 702-558-0094 Fax: 702-558-0079 www.gmpseminars.com Key to Level of Program Level A: Program
More informationCatalog. Global Education. and Training. Global Expertise Trusted Standards Improved Health
Global Education Catalog 2013 2014 and Training Global Expertise Trusted Standards Improved Health USP s mission is to improve global health through public standards and related programs that help ensure
More informationRisk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI
Risk-Based Environmental Monitoring Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI Presenter Marsha Stabler Hardiman Over 20 years experience in the
More informationPreparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant
Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives Barry A. Friedman, Ph.D. Consultant FDA Overview FDA is a consumer protection agency within the Department of Health & Human
More informationICH Topic Q 1 A Stability Testing Guidelines: Stability Testing of New Drug Substances and Products
The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit CPMP/ICH/380/95 ICH Topic Q 1 A Stability Testing Guidelines: Stability Testing of New Drug Substances and Products
More informationHAZARD ANALYSIS CRITICAL CONTROL POINT PLAN SUMMARY SETHNESS PRODUCTS COMPANY LIQUID CARAMEL COLOR
HAZARD ANALYSIS CRITICAL CONTROL POINT PLAN SUMMARY SETHNESS PRODUCTS COMPANY LIQUID CARAMEL COLOR I. INTRODUCTION A. CARAMEL COLOR 1. Caramel Color (Caramel) is defined in Title 21 of the U.S. Code of
More informationMeriCal Quality Profile
January 5, 2015 Dear Valued Customer, Since the implementation of new federal regulations, MeriCal Inc. has received a large volume of questionnaires and surveys regarding our services and procedures.
More informationGuidance for Industry
Guidance for Industry INDs for Phase 2 and Phase 3 Studies Chemistry, Manufacturing, and Controls Information U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
More informationA Process Verification Model Quality Assurance in a Compounding Pharmacy
ba ic f c mp unding quali y-c n l analy ical me d p e c ip i n A Process Verification Model calcula for i n Quality Assurance in a ma ke ing Compounding Pharmacy Abstract There are virtually thousands
More informationGuidance for Industry ANDAs: Stability Testing of Drug Substances and Products
Guidance for Industry ANDAs: Stability Testing of Drug Substances and Products Questions and Answers U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
More informationcgmp Challenges for Cord Blood Banks
cgmp Challenges for Cord Blood Banks Donna M. Regan, MT(ASCP)SBB St. Louis Cord Blood Bank @ SSM Cardinal Glennon Children s s Medical Center Cord Blood Bank processing facility challenges What does cgmp
More informationAnnex 7 Guidelines on pre-approval inspections
World Health Organization WHO Technical Report Series, No. 902, 2002 Annex 7 Guidelines on pre-approval inspections 1. General 94 2. Glossary 94 3. Objectives 95 4. Priorities 96 5. Preparation for the
More informationHighly Potent APIs The right platform, people and procedures for successful development and manufacturing
Pharma&Biotech Highly Potent APIs The right platform, people and procedures for successful development and manufacturing Custom Manufacturing and Development Services for Highly Potent APIs Pharma&Biotech
More informationANDA CHECKLIST FOR CTD or ectd FORMAT FOR COMPLETENESS and ACCEPTABILITY of an APPLICATION FOR FILING
ANDA CHECKLIST FOR CTD or ectd FORMAT FOR COMPLETENESS and ACCEPTABILITY of an APPLICATION FOR FILING For More Information on Submission of an ANDA in Electronic Common Technical Document (ectd) Format
More informationQuality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion
Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS Eli Lilly & Co. Principal Consultant - Regulatory PDA/FDA Joint September 20 th, 2011
More informationAnnex 6. Guidance on variations to a prequalified product dossier. Preface
Annex 6 Guidance on variations to a prequalified product dossier Preface This guidance document was technically and structurally inspired by the Guideline on dossier requirements for type IA and IB notifi
More informationManufacturing process of biologics
Manufacturing process of biologics K. Ho Afssaps, France 2011 ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use 2011 ICH 1 Disclaimer:
More informationCleaning Validation in Active pharmaceutical Ingredient manufacturing plants
Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants September 1999 Table of contents 1. Foreword...... 2 2. Objective...... 3 3. Scope........ 4 4. Potential residues... 5 5. Current
More information2014 Annual Report on Inspections of Establishments
2014 Annual Report on Inspections of Establishments Table of Contents Introduction... 2 Data Collection and Definitions... 3 Section 510(h)(6)(A)(i) Number of Domestic and Foreign Establishments Registered
More informationDepartment of Food Science Food Processing FSE98(10-99)
Department of Food Science Food Processing FSE98(10-99) Choosing and Using a Copacker John E. Rushing, Ph.D. What is a copacker? Copackers manufacture and package foods for other companies to sell. These
More informationSupply Chain Challenges and Risk Management
Supply Chain Challenges and Risk Management Presented by Steve Williams Director SeerPharma P/L 21 st April 2009 PDA April 09 SW 1 Supply Chain - Some Useful Guidance cgmp Annex 8 cgmp Chapter 7 ICH Q7
More informationGMP Pharma BV. Netherlands
GMP Pharma BV Netherlands Connecting the European & Indian Pharmaceutical, Biotechnology and Biopharmaceutical Industry for parallel growth and solicitation. About Us: GMP Pharma BV is a multisource organization
More informationCleanroom. For. Sterile Manufacturing Facilities
Cleanroom For Sterile Manufacturing Facilities Praphon Angtrakool Food and Drug Administration 1 WHO TRS No. 823 Annex 1, 1992 (1) General 17.1 The production of sterile preparations should be carried
More informationXiaoming Wang, MD. MS. Manager QC Microbiology ImClone Systems A wholly-owned subsidiary of Eli-Lilly and Company
Xiaoming Wang, MD. MS Manager QC Microbiology ImClone Systems A wholly-owned subsidiary of Eli-Lilly and Company USP Microbiological Best Laboratory Practices USP 32 page 616 Introduction: good laboratory
More informationPharmacy Technician Training Program. Minimum Competencies
1. Pharmacy Practice Pharmacy Technician Training Program Minimum Competencies 1.1 The candidate shall be familiar with the mission of pharmacy and the various permitted pharmacy practice sites. The candidate
More informationStep-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry
Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry BY GHULAM A. SHABIR Introduction Methods Validation: Establishing documented evidence that provides a high
More informationQuestionnaire Layout:
Raw Material Supplier Questionnaire Introduction: This questionnaire has been developed by the EHPM quality working group. It combines work carried out by EHPM various national associations in developing
More informationGuideline on Process Validation
1 2 3 4 29 March 2012 EMA/CHMP/CVMP/QWP/70278/2012-Rev1 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) 5 6 Draft Draft Agreed by CHMP /
More informationGuidance for Industry Pyrogen and Endotoxins Testing: Questions and Answers
Guidance for Industry Pyrogen and Endotoxins Testing: Questions and Answers U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center
More informationJANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS
JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS 1 WHAT IS A SITE MASTER FILE? A Site Master File (SMF) is a document prepared by the manufacturer containing specific
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS
European Medicines Agency Inspections London, 21 June 2006 Doc Ref.: EMEA/CHMP/QWP/49313/2005 Corr COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION
More informationFILTRATION SOLUTIONS PhARmAceUTIcAL manufacturing FILTRATION SPecIALISTS
FILTRATION SOLUTIONS Pharmaceutical Manufacturing filtration specialists Delivering quality filtration products As one of Europe s leading manufacturers of process filters, Amazon Filters is able to offer
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE THE COMMON TECHNICAL DOCUMENT FOR THE REGISTRATION
More informationQuality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:
NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a
More informationAnnex 9 Guide to good storage practices for pharmaceuticals 1
World Health Organization WHO Technical Report Series, No. 908, 2003 Annex 9 Guide to good storage practices for pharmaceuticals 1 1. Introduction 125 2. Glossary 126 3. Personnel 128 4. Premises and facilities
More informationGuidance for Industry
Guidance for Industry Container and Closure System Integrity Testing in Lieu of Sterility Testing as a Component of the Stability Protocol for Sterile Products For questions on the content of the guidance,
More informationGlobal Lab Capabilities Pharma Biotech
Global Lab Capabilities Pharma Biotech NSF Health Sciences global network of laboratories delivers expert solutions to pharmaceutical, biotechnology and medical device companies in the areas of analytical
More informationBasic Requirements For Aseptic Manufacturing Of Sterile Medicinal Products A Comparison Between Europe And USA
Basic Requirements For Aseptic Manufacturing Of Sterile Medicinal Products A Comparison Between Europe And USA Wissenschaftliche Prüfungsarbeit zur Erlangung des Titels Master of Drug Regulatory Affairs
More informationOverview of Pre-Approval Inspections
Overview of Pre-Approval Inspections Presented by: Kelli F. Dobilas NWJ-DO Pre-Approval Manager Pre-Approval Drug Inspections What are Pre-Approval Inspections? One of the last reviews of the drug approval
More informationAnnex 7 WHO guidelines on transfer of technology in pharmaceutical manufacturing
World Health Organization WHO Technical Report Series, No. 961, 2011 Annex 7 WHO guidelines on transfer of technology in pharmaceutical manufacturing 1. Introduction 2. Scope 3. Glossary 4. Organization
More informationtdodds@jeffyuen.com 714 282-1014 Jeff Yuen and Associates, Inc. PO Box 6026 Orange, CA 92863 Terri Dodds CAPT. (RET) TERRI L.
SKILLS/SPECIAL QUALIFICATIONS: Regulatory Expertise: Technical Expertise: CAPT. (RET) TERRI L. DODDS - BSN, RN Former Public Health Service (PHS) Officer with 16 years of FDA experience in Pharmaceuticals,
More informationLIBRARY GUIDE. Online Courses. March 2012
LIBRARY GUIDE Online Courses March 2012 i Table of Contents OVERVIEW..................................................................................... 1 COURSE DESCRIPTIONS (LISTED ALPHABETICALLY)...............................................
More informationRESOLUTION-RDC Nr- 48, OF OCTOBER 6, 2009
RESOLUTION-RDC Nr- 48, OF OCTOBER 6, 2009 This resolution provides for the alteration, inclusion, suspension, reactivation and cancellation after registration of medications and sets forth other provisions.
More informationDiane Kadidlo MT(ASCP) SBB University of Minnesota Joanna Stanson, M.S. University of Pittsburgh
Production Records & Documentation Diane Kadidlo MT(ASCP) SBB University of Minnesota Joanna Stanson, M.S. University of Pittsburgh Production Records This Session: Production Records Basic Elements Regulatory
More informationCleaning. By the end of this chapter, you will be able to: Introduction. Definitions. Chapter 9
Chapter 9 By the end of this chapter, you will be able to: l Define the terms cleaning, decontamination, disinfection l List the factors that affect disinfection l Describe the aims of a cleaning schedule
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL
More informationGOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL INGREDIENTS
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE DRAFT CONSENSUS GUIDELINE GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL
More information*XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV
WHO/VSQ/97.03 Original: English Distribution: General *XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV 3UHSDUHGE\*LOOLDQ&KDORQHU/DUVVRQ3K'*&/%LRFRQVXOW 2WWDZD&DQDGD /LQNWR&RQWHQWVSDJH GLOBAL PROGRAMME
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL Site Master File GUIDELINES FOR PREPARATION OF SITE MASTER FILE This document has been prepared as a guide to assist applicants to comply with the requirements for Site Master
More informationMicrobiological Best Laboratory Practices, USP <1117> Value and Recent Changes to a Guidance of Quality Laboratory Practices
«MICROBIOLOGY» Microbiological Best Laboratory Practices, USP Value and Recent Changes to a Guidance of Quality Laboratory Practices Scott Sutton 1, Ph.D. and Donald Singer 2 1 President, Microbiology
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products- authorisations, European Medicines Agency Brussels, EudraLex The Rules Governing Medicinal
More informationGUIDELINES FOR MANAGEMENT AND HANDLING OF SPENT MYCELIUM FROM BULK DRUG INDUSTRY
GUIDELINES FOR MANAGEMENT AND HANDLING OF SPENT MYCELIUM FROM BULK DRUG INDUSTRY MAHARASHTRA POLLUTION CONTROL BOARD Kalpataru Point, Sion (E), Mumbai 400 022. E-mail : mpcb@vsnl.net Web site : http://mpcb.mah.nic.in
More informationPharmaceuticals Production Services Boehringer Ingelheim. Our expertise in world-class contract manufacturing for your success
Pharmaceuticals Production Services Boehringer Ingelheim Our expertise in world-class contract manufacturing for your success Successful partnership Dr Wolfram Carius Head of Corporate Division Pharmaceuticals
More informationSERVICES FOR. Devices and Combination Products
SERVICES FOR Devices and Combination Products How to Contact Us U.S. FACILITIES / CLIENT SERVICES St. Paul 2540 Executive Drive St. Paul, MN 55120 FAX 651.675.2005 Atlanta 1265 Kennestone Circle Marietta,
More informationEC 691 January 1996 HACCP AND MICROBREWERIES PRACTICAL GUIDELINES OF FOOD SAFETY FOR MICROBREWERIES, BREWPUBS AND THE BEER INDUSTRY
EC 691 January 1996 HACCP AND MICROBREWERIES PRACTICAL GUIDELINES OF FOOD SAFETY FOR MICROBREWERIES, BREWPUBS AND THE BEER INDUSTRY TABLE OF CONTENTS I. Purpose of this publication... 3 II. Introduction...
More informationOpen Microphone Meeting:
Open Microphone Meeting: USP General Chapter Pharmaceutical Compounding Sterile Preparations October 21, 2015 2:00 p.m. to 4:00 p.m. EDT Agenda Welcome Overview of USP s Revision Process Overview
More informationPharmaceutical Quality Systems: US Perspective
Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical
More informationOxivir Tb and Accelerated Hydrogen Peroxide (AHP) Frequently Asked Questions
Oxivir Tb and Accelerated Hydrogen Peroxide (AHP) Frequently Asked Questions What is Accelerated Hydrogen Peroxide (AHP)? AHP is a patented synergistic blend of commonly used, safe ingredients that when
More informationUSP s mission is to improve global health through public. standards and related programs that help ensure the quality,
2015 Catalog USP s mission is to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. 2 Courses listed as of January
More informationPEOPLE > SCIENCE > SOLUTIONS
PEOPLE > SCIENCE > SOLUTIONS Our difference Our foundation Our focus ANALYTICAL CHEMISTRY & MATERIALS CHARACTERIZATION EFFICACY (Functional testing) BIOCOMPATIBILITY (in vivo & in vitro toxicology) CLINICAL
More informationPosition Classification Standard for Pharmacy Technician Series, GS-0661
Position Classification Standard for Pharmacy Technician Series, GS-0661 Table of Contents SERIES DEFINITION... 2 SERIES COVERAGE... 2 EXCLUSIONS... 4 TITLES... 4 NOTES TO USERS OF THIS STANDARD... 5 CLASSIFICATION
More informationStandards for the initial education and training of pharmacy technicians
Standards for the initial education and training of pharmacy technicians September 2010 2 Standards for the initial education and training of pharmacy technicians The General Pharmaceutical Council is
More informationCord Blood Licensure. Session 2C: Advanced Cell Therapies April 11, 2013
Cord Blood Licensure Session 2C: Advanced Cell Therapies April 11, 2013 Objectives Describe rationale for cord blood licensure Cite licensure regulations Illustrate a case study of one program s pathway
More informationQuality assurance of pharmaceuticals
QAPPR 12/16/06 12:10 PM Page i Quality assurance of pharmaceuticals A compendium of guidelines and related materials Volume 2, 2nd updated edition Good manufacturing practices and inspection QAPPR 12/16/06
More informationThe Formalized Risk Assessment for Excipients A Practical Approach. Frithjof Holtz, IPEC Europe Vice-Chair, Merck
The Formalized Risk Assessment for Excipients A Practical Approach Frithjof Holtz, IPEC Europe Vice-Chair, Merck Presentation Overview Regulatory Background EU FMD and Formalized Risk Assessment Proposal
More informationScanning Electron Microscopy Services for Pharmaceutical Manufacturers
Scanning Electron Microscopy Services for Pharmaceutical Manufacturers Author: Gary Brake, Marketing Manager Date: August 1, 2013 Analytical Testing Laboratory www.atl.semtechsolutions.com Scanning Electron
More informationBiotechpharma company profile
Biotechpharma company profile October 2013 1 History 2004 Biotechpharma UAB established as a proteomic research company in Vilnius, Lithuania 2005 Company became a member of UK s Northway group, investing
More informationAnnex 7 Application of Hazard Analysis and Critical Control Point (HACCP) methodology to pharmaceuticals
World Health Organization WHO Technical Report Series, No. 908, 2003 Annex 7 Application of Hazard Analysis and Critical Control Point (HACCP) methodology to pharmaceuticals 1. Introduction Traditionally,
More informationDesign, Operation and Management of GTP/GMP Cell Engineering Facilities
Design, Operation and Management of GTP/GMP Cell Engineering Facilities Scott R. Burger, MD Advanced Cell & Gene Therapy BFDA 2007 International Symposium on Regulation of Human Cell and Tissue- Based
More informationCombination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma
Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)
More informationThe Use of Enzymes in Dietary Supplements USP Enzyme Workshop July 8, 2009
The Use of Enzymes in Dietary Supplements USP Enzyme Workshop July 8, 2009 Nena Dockery Introduction and History of Use Commercial production of enzymes for use as digestive aids has an extensive history
More informationWorkshop A Design Space (DS)
Implementation of ICH Q8, Q9, Q10 Workshop A Design Space (DS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Disclaimer The information
More informationGMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 032-2 8 January 2010 RECOMMENDATION GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE
More informationCOMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance
More informationPHARMACEUTICAL TRAINING GUIDELINE
PHARMACEUTICAL TRAINING GUIDELINE 5850 Boymel Dr. Suite 1 Fairfield, OH 45014 Tel.: 513.860.3512 Fax: 513.860.3406 www.compliance-insight.com Reorder Item No. 20.020.2 PHARMACEUTICAL TRAINING GUIDELINE
More informationPharmacy Investigational Drug Services for Clinical Research
Pharmacy Investigational Drug Services for Clinical Research Jennifer Colon, PharmD, MS, MBA Pharmacy Clinical Specialist-Investigational Drug Services Temple University Hospital Adjunct Clinical Professor-Temple
More information[See Rules 74,74-A, 74-B, 78 and 78-A] A. SUBSTANCES OTHER THAN PARENTERAL IN PREPARATIONS IN GENERAL
29 [SCHEDULE U [See Rules 74,74-A, 74-B, 78 and 78-A] I. Particulars to the shown in /manufacturing Records A. SUBSTANCES OTHER THAN PARENTERAL IN PREPARATIONS IN GENERAL 1. Serial number. 2. Name of the
More informationExtemporaneously Prepared Early Phase Clinical Trial Materials
Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS, RAC Eli Lilly & Co. Regulatory Advisor International Consortium for Innovation & Quality in Pharmaceutical Development
More informationGuidance for Industry
Guidance for Industry Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
More informationICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/ biological entities)
November 2012 EMA/CHMP/ICH/425213/2011 ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/ biological entities) Step 5 Transmission to CHMP May
More informationInternational GMP Requirements for Quality Control Laboratories and Recomendations for Implementation
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. ludwig_huber@labcompliance.com Overview GMP requirements for Quality Control laboratories
More informationAnnex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1
Annex 2 WHO good manufacturing practices for pharmaceutical products: main principles 1 Introduction 79 General considerations 80 Glossary 81 Quality management in the medicines industry: philosophy and
More informationSPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT
SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT Guideline Title Specifications and Control Tests on the Finished Product Legislative basis Directive 75/318/EEC as amended Date of first adoption
More information